Diabetic retinopathy (DR) is a substantial worldwide public health burden: in 2010, it was estimated to affect 93 million people worldwide.
1 In particular, it is the leading cause of blindness in the working population of the United States and European Union.
2,3 Detecting DR in the at-risk population (diabetics), generally using eye fundus photography, is crucial for providing timely treatment of DR and, therefore, preventing visual loss.
4 In the past decade, faced with the increase of the at-risk population,
5 retinal screening programs for diabetic retinopathy have experienced rapid growth.
6–11 To expand these screening programs into rural areas, through highly distributed primary care facilities
12,13 or through mobile imaging units,
14–16 it would be beneficial to have access to low-cost, portable, easy-to-operate, and high image quality fundus cameras. This is of particular importance in low and middle income countries.
17,18 Additionally, it should be noted that mydriatic fundus photography, which implies pharmacologically dilating the pupil, limits the widespread use of fundus photography. Therefore, nonmydriatic fundus cameras would be a better option.
A few low-cost, handheld, nonmydriatic eye fundus cameras are now commercially available: Smartscope Pro (Optomed, Oulu, Finland), commercialized in the United States as Pictor (Volk Optical, Mentor, OH, USA), VersaCamTM DS-10 (Nidek, Gamagori, Japan), Horus DEC 200 (MiiS, Hsinchu, Taiwan), as well as Genesis-D (Kowa, Nagoya, Japan), although the last one is more voluminous. These devices have advanced features comparable to more expensive, nonportable fundus cameras: internal fixation targets, autofocus, and high-resolution images (e.g., 5 mega-pixels). Besides these commercially available solutions, various prototypes are under development,
19,20 including by Epipole (Dunfermline, UK)
21 and IDx (Iowa City, IA).
22
It should be noted that smartphone-based solutions also have been proposed. Fundus images can be taken directly from a smartphone, using a more or less compact adaptor: Peek Vision (Nesta, London, UK),
23 PanOptic + iExaminer (Welch Allyn, Skaneateles Falls, NY), and D-Eye (D-EYE, Padova, Italy).
24 However, these solutions currently have drawbacks: Peek Vision and D-Eye are mydriatic, and PanOptic and D-Eye have limited fields of view (25° and 20°, respectively). Note that Fundus-ON-phone (Remidio, Bengaluru, India) also is smartphone-based, but it is not handheld.
Two studies have reported comparisons between low-cost, handheld, mydriatic devices and their more expensive, nonportable counterparts. In a first study, involving six patients, a handheld prototype by the authors and a TRC-50EX camera (TopCon Medical Systems, Tokyo, Japan) were compared.
20 Mydriatic imaging modalities were comparable in terms of image quality. In a second study, the D-Eye adaptor, mounted on an iPhone 5 (Apple, Cupertino, CA), was compared to retinal slit-lamp examination, also after pupil dilation.
24 Mydriatic imaging modalities were comparable in terms of DR diagnostic performance (
κ = 0.78).
To the best of our knowledge, in the case of nonmydriatic cameras, no such comparison was ever published in the literature. The purpose of this study was to compare the Horus DEC 200 (MiiS) to the AFC-330 (Nidek), in terms of ease of image acquisition, image quality, and DR diagnosis performance.